Antiinflammatory Therapy with Canakinumab for Atherosclerotic DiseasePaul M. Ridker, Robert J. Glynn, Tom Thurén et al.|New England Journal of Medicine|2017Cited by 9.1k
From Vulnerable Plaque to Vulnerable PatientMorteza Naghavi, Sanjay Kaul, Gerard Pasterkamp et al.|Circulation|2003Cited by 2.7k
From Vulnerable Plaque to Vulnerable PatientMorteza Naghavi, Sanjay Kaul, Peter Libby et al.|Circulation|2003Cited by 2.3k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trialPaul M. Ridker, Hakan Kültürsay, Jean MacFadyen et al.|The Lancet|2017Cited by 1.3k
Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated PatientsStephen J. Nicholls, Steven E. Nissen, Rishi Puri et al.|JAMA|2016Cited by 1.1k